A switch from tenofovir to entecavir prior to hepatitis B treatment cessation is associated with a reduced risk of off-therapy relapse: An observational study

Please use this identifier to cite or link to this item: http://ir.sinica.edu.tw/handle/201000000A/88537

Title:	A switch from tenofovir to entecavir prior to hepatitis B treatment cessation is associated with a reduced risk of off-therapy relapse: An observational study
Authors:	Peng, CW Jeng, WJ Yang, HI Liu, YC Chien, RN Liaw, YF
Issue Date:	2022
Relation:	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 37(11), 2164-2172
URI:	http://ir.sinica.edu.tw/handle/201000000A/88537
ISSN:	http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Drexel&SrcApp=hagerty_opac&KeyRecord=0815-9319&DestApp=JCR&RQ=IF_CAT_BOXPLOT
URL:	http://dx.doi.org/10.1111/jgh.15966
Appears in Collections:	基因體研究中心

Show full item record

checked on May 9, 2025

Check